Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Translucent AI develops an AI-powered financial platform tailored for healthcare operators.
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Nitra is overhauling the healthcare industry with radically efficient and transparent solutions - starting with spend management.
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
Samaya AI specializes in developing AI research agents that streamline knowledge workflows.
Tulip is a frontline operations platform designed to empower companies with AI-enabled, connected applications.
Recludix pharma is a developing platform to treat cancer patients.
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Phathom Pharmaceuticals is a biopharmaceutical company.
Cohere is a software company focused on mobile technology.
Mejuri is a direct to consumer fine jewelry brand that introduces handcrafted, everyday jewelry without the traditional retail markup.
Tailor is a no-code headless ERP platform helping retail businesses unify tools, marketplaces, and teams on one system.
Chaos is a defense technology company that develops advanced sensing, detection, and communication technologies for the military sectors.
Fabric8Labs is a machinery company that specializes in metal 3D printing.
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
Clio provides cloud-based legal practice management software, helping law firms manage cases, billing, and client relationships.
Popai Health uses care coordination calls to extract important insights.
Spiras Health is an operator of a healthcare company intended to extend the care of a patient dealing with complex chronic illness.
Synthesia is an AI video platform that enables users to create videos from text using advanced AI avatars and voiceovers.
Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.
CoreStory provides a platform that helps enterprises understand their legacy code.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Uniphore is a business-software company that provides a secure AI platform that deploys agentic AI across every enterprise function.
FiscalNote uses artificial intelligence and big data to deliver predictive analytics on government information to determine its impact.
New Enterprise Associates has invested in 643 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
New Enterprise Associates's top investment sectors include Health Care, Artificial Intelligence (AI), Biotechnology, Software, Medical. The firm invests across 49 different industry categories.
Among tracked funding rounds, Resilience received $825.0M in a Debt Financing round. New Enterprise Associates's total known invested capital is $44.2B.
New Enterprise Associates's average investment size is $68.8M across its portfolio of 643 companies.
Recent New Enterprise Associates portfolio additions include Translucent AI, CRISPR Therapeutics, Nitra, Korro Bio, Samaya AI. These companies were founded in 2020 or later.